Ascension account plan
Healthcare services and innovation
At a glance
Ascension is a US Catholic nonprofit health system with 91 consolidated hospitals, 98,500 associates and $24,473 million FY2026 operating revenue.
Ascension is one of the largest Catholic, nonprofit health systems in the United States, sponsored by five religious congregations and organised in regional Ministry Markets such as Ascension Seton (Texas), Ascension Saint Thomas (Tennessee) and Ascension St. Vincent (Indiana). At September 30, 2026 it had about 98,500 associates and 27,700 aligned providers across 35 states and the District of Columbia, 91 wholly owned or consolidated hospitals, interests in 32 more, 306 ambulatory surgery centers and 20 senior living facilities. In the fiscal year ended June 30, 2026 total operating revenue was $24,473 million, the loss from operations $120 million and net income $1,505 million, driven by investment gains. The June 2026 acquisition of AmSurg made it a large ambulatory surgery platform. Eduardo Conrado has been President and CEO since January 1, 2026.
Business units
Inpatient care (hospitals)
about 42% of FY2026 operating revenue ($10,276 million)Acute care in 91 consolidated hospitals across the Ministry Markets. Ascension has divested hospitals in Michigan, Chicago and Alabama and now targets about 3% acute growth in its markets, with a Williamson Health acquisition in Tennessee pending.
Ambulatory care
about 37% of FY2026 operating revenue ($9,132 million)Outpatient services, emergency departments, imaging and ambulatory surgery, including AmSurg since June 4, 2026. AmSurg added 283,000 outpatient surgeries in Q1 FY2027, and the CEO sees a 10%-plus growth rate for ambulatory.
Physician practices
about 8% of FY2026 operating revenue ($2,021 million)Employed and aligned physician groups with 27,000 aligned providers at June 30, 2026; revenue fell from $2,292 million as divestitures rolled off.
Ascension Rx (pharmacy)
about 3.5% of FY2026 operating revenue ($867 million)Retail and specialty pharmacy, with specialty services and a national mail-order platform named as a key priority; it also distributes donated medicines through Dispensary of Hope.
Ascension Living (senior living)
about 1% of FY2026 operating revenue ($340 million)Senior living facilities, down to 20 at September 30, 2026 after sales and the Chicago divestiture.
Services, insurance and unconsolidated entities
Contracted services of $648 million in FY2026, including revenue cycle, IT and finance services for Henry Ford Health, in which Ascension holds 20%; income from over 150 unconsolidated entities. The Mercy Care health plan was sold to CVS Pharmacy in October 2026.
Ascension Capital and enterprise subsidiaries
Ascension Investment Management runs the investment portfolio and the Alpha Fund, Ascension Ventures invests in healthcare companies, and The Resource Group handles national supply contracting, alongside Ascension Technologies and captive insurers.
Strategic priorities
- Shift care to ambulatory settings
- Ascension is expanding ambulatory, virtual and community-based care and moving procedures out of hospitals; ambulatory and ancillaries grew at a 20 percent compound annual rate over four years.
- Grow through AmSurg
- AmSurg lets Ascension enter 25 new markets through surgery centers and partnerships with independent physicians and health systems, without building acute hospitals.
- Margin targets
- Ascension targeted an operating income margin of 0.5% for FY2026, about 2% by fiscal 2027 and about 3% by fiscal 2028, with M&A potentially lifting it to roughly 4%.
- Ancillaries and pharmacy
- Growth in imaging, outpatient therapy and Ascension Rx specialty pharmacy and national mail order is a stated priority.
- Access for Medicaid and uninsured patients
- With more than one million patients a year on Medicaid or uninsured, Ascension is extending hours, virtual care and FQHC data sharing to reduce emergency department overuse.
- AI in care and access
- The CEO expects AI to play a significant role in clinical settings, access, consumer interaction and scheduling.
Latest results
In the first quarter of fiscal 2027 (three months to September 30, 2026), the first full quarter with AmSurg, total operating revenue rose to $6,447 million from $6,136 million and net patient service revenue 9.3% to $5,890 million. Recurring operating EBIDA was $229 million, a 3.6% margin against 3.4%, while the recurring operating loss stayed at $86 million. Operating expenses rose 4.4%, led by salaries and supplies. Lower investment gains ($169 million against $569 million) turned net income to a $34 million loss. Days cash on hand fell to 219. For full FY2026, same-facility operating revenue rose 9.8% to $24.1 billion. No numeric guidance is published in the financial documents.
Investments and deals
- AmSurg acquisition
- Ascension acquired AmSurg in June 2026 for about $3.8 billion (announced as a $3.9 billion agreement), bringing roughly 300 ambulatory surgery centers.
- Hospital acquisitions
- Ascension bought Cedar Park Regional Medical Center in June 2025, is acquiring Williamson Health in Tennessee, and signed in October 2026 to acquire 3 healthcare facilities from Cedar Park in Texas.
- Facility projects
- Projects include a new patient tower at Ascension Seton Williamson, a 40-bed inpatient rehabilitation facility in Florida, an east Wichita emergency department and a $120 million campus renovation at Ascension Saint Thomas Hospital West; construction commitments were about $769 million at June 30, 2026.
- Divestitures
- Since 2024 Ascension sold or contributed hospitals in Michigan, Chicago and Alabama, and sold the Mercy Care health plan to CVS Pharmacy in October 2026.
- Bond financing
- Ascension raised about $2.1 billion of taxable bonds in November 2025 and about $2.5 billion of tax-exempt bonds in December 2025 for capital projects and refundings.
Challenges and risks
- Cost inflation
- Average hourly wages rose 4.3% in FY2026, and supplies rose 12.1% in Q1 FY2027 on high-cost devices and pharmaceuticals, alongside rising provider taxes.
- Rising uninsured population
- Medicaid reductions and the loss of ACA tax credits are expected to increase the number of uninsured patients Ascension serves.
- AmSurg integration
- The CFO says making the acquisition successful "is a whole other journey", and the purchase price allocation stays provisional until June 4, 2027.
- Leverage and investment dependence
- Total debt to capitalization rose to 31.1% from 22.0%, Fitch downgraded Ascension to AA, and the bottom line depends heavily on investment returns.
What leadership says
“Success is no longer defined by the number of hospitals in a portfolio, but by whether people can access care when and where they need it.”
“The ambulatory space has a 10%-plus CAGR going forward, and then our acute side, for the markets that we're in, about 3%.”
“Healthcare is increasingly moving beyond the traditional hospital setting, and this acquisition positions us to lead that transformation.”
“One thing we will never walk away from is our mission …. but we do want to take the care out of hospitals.”
Where a supplier can help
- Ambulatory surgery operations
- Integrating AmSurg and entering 25 new markets creates needs for ASC equipment, scheduling, staffing and integration services.
- Supply and device cost control
- Supply costs rising on devices and pharmaceuticals, with mitigation run through The Resource Group, favour suppliers that cut implant, catheter or drug cost.
- AI for access and scheduling
- The CEO's view that AI will matter in access, consumer interaction and scheduling, plus virtual care for uninsured patients, opens room for digital front door and scheduling tools.
- Specialty pharmacy and mail order
- The Ascension Rx priority on specialty pharmacy and national mail order fits pharmacy logistics and fulfilment partners.
- Margin improvement
- Targets of about 2% operating margin by fiscal 2027 and about 3% by fiscal 2028 reward vendors that lower cost per case or improve revenue cycle.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Ascension?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Consolidated Financial Statements and Management's Discussion and Analysis, fiscal year ended June 30, 2026
- Ascension (Ascension Health Alliance) is a Catholic, nonprofit national health system incorporated in Missouri: about 98,100 associates and 27,000 aligned providers in 36 states and the District of Columbia at June 30, 2026, operating 91 wholly owned or consolidated hospitals, noncontrolling interests in 27 more, 312 ambulatory surgery centers and 22 senior living facilities.
- FY2026 (year to June 30, 2026): total operating revenue $24.5 billion ($24,473 million, down from $25,326 million as divestitures rolled off); same-facility operating revenue up $2.2 billion (9.8%) and same-facility net patient service revenue up $2.0 billion (10.5%).
- Operating loss narrowed to $120 million from $491 million; recurring operating EBIDA rose to $1,225 million (5.0% margin) from $837 million (3.3%). Net income excluding noncontrolling interests was $1,505 million, carried by $2.1 billion of net investment gains.
- Revenue mix: inpatient care $10.3 billion and ambulatory care $9.1 billion of net patient service revenue; payors are 44.3% commercial/managed care, 33.3% Medicare and 15.7% Medicaid.
- June 2026: acquired AmSurg, a for-profit ambulatory surgery development and management company, for about $3.8 billion (consideration paid $3,838 million, goodwill $4.3 billion); funded partly by $2.1 billion of taxable bonds issued in November 2025.
- Portfolio reshaped since 2024: Michigan hospitals to Henry Ford Health (20% stake kept, valued at about $1.35 billion), nine Chicago-area hospitals sold to Prime, Alabama to UAB, four Michigan hospitals to Beacon; Mercy Care health plan agreed for sale to CVS (July 2026).
- Strategic priorities: ambulatory, virtual and community-based care, ancillaries (imaging, outpatient therapy), Ascension Rx specialty pharmacy and national mail order, and ambulatory surgery through AmSurg.
- Balance sheet: total assets $47.8 billion, $15.1 billion net unrestricted cash and investments, 233 days cash on hand; long-term debt rose to $9.1 billion and total debt to capitalization to 31.1%.
- Leadership: Eduardo Conrado became President and CEO on January 1, 2026, succeeding Joseph Impicciche; auditor Ernst & Young issued an unqualified opinion on September 16, 2026.
- Management's Discussion and Analysis, first quarter fiscal 2027 (three months ended September 30, 2026)
- Q1 FY2027 (quarter to September 30, 2026): total operating revenue $6.5 billion ($6,447 million), up $311 million (5.1%); net patient service revenue up $502 million (9.3%) to $5,890 million, boosted by the AmSurg acquisition.
- Recurring operating EBIDA $229 million (3.6% margin) vs $207 million (3.4%); recurring operating loss flat at $86 million (margin (1.3%) vs (1.4%)). Excluding self-insurance trust fund investment swings, EBIDA would have improved $60 million.
- Net loss of $34 million excluding noncontrolling interests vs net income of $338 million a year earlier, driven by a $400 million drop in non-operating investment income.
- Volumes: equivalent discharges +9.1%, total discharges +3.4%, ER visits +4.5%; outpatient surgery visits +399.4% because AmSurg contributed 283,000 surgical visits (+3.6% excluding AmSurg).
- Other operating revenue fell $191 million as transition service agreements from divestitures expired and Medicare shared savings revenue dropped.
- Scale at September 30, 2026: about 98,500 associates, 27,700 aligned providers, 35 states and DC, 91 consolidated hospitals, interests in 32 more, 306 ASCs, 20 senior living facilities.
- Portfolio: Mercy Care health plan sale to CVS closed October 2026; Williamson Health deal pending; definitive agreement to acquire 3 Cedar Park, Texas facilities.
- Liquidity: $15.1 billion net unrestricted cash and investments; days cash on hand fell to 219 from 233 on higher post-AmSurg daily expenses; cash-to-debt 142.9%.
- CEO Viewpoint: Eduardo Conrado, President & CEO, Ascension (Scottsdale Institute, April 2026)
- Eduardo Conrado, CEO since January 2026 after three years as president, describes his first 100 days as continuity: "we were not making a hard right or left turn" but accelerating the existing strategy.
- Four priorities: Mission at the centre, continuing the strategy, "a disciplined approach to capital deployment", and a strong focus on talent, with execution and accountability.
- Portfolio shift: Ascension has divested hospitals and reduced its acute footprint while growing ambulatory and ancillaries at a 20 percent compound annual growth rate over four years; capital will go more to ambulatory sites.
- Operating model credited with improving the system by $2.5 billion over three years.
- Serves more than one million Medicaid or uninsured patients a year and expects the uninsured number to grow with Medicaid reductions and the loss of ACA tax credits.
- Answer to ED overuse: closer work with FQHCs, extended hours and virtual care, Dispensary of Hope donated medicines via Ascension Rx pharmacies, extended through mail order.
- Technology view from a former Motorola engineer: AI will matter in clinical care, access, consumer interaction and scheduling, but should "strengthen human connection, not replace it".
- Hospitals remain for high-acuity patients while more procedures move to ambulatory settings, under Medicare first and commercial following.
- JPM26: Ascension CEO says AmSurg deal opens new markets, physician partnerships
- At the J.P. Morgan Healthcare Conference (January 2026), CEO Eduardo Conrado said the $3.9 billion AmSurg deal lets Ascension enter 25 new markets and deepen partnerships with independent physicians and health systems.
- AmSurg adds more than 250 managed ASCs across 34 states; Ascension expected to become the third-largest ASC platform (more than 300 centers) and the seventh-largest health system by hospital footprint (95 wholly owned hospitals and 26 joint ventures).
- In the 25 new markets Ascension does not plan acute care facilities; it will use ASCs to partner with independent physicians and local health systems, positioning itself as a preferred partner rather than a hospital competitor.
- In core markets, AmSurg centers shift lower-acuity procedures out of hospitals; new wholly owned ASCs could help with a potential rise in uninsured patients.
- Growth view: "The ambulatory space has a 10%-plus CAGR going forward, and then our acute side, for the markets that we're in, about 3%".
- Margin targets: operating margin of 0.5% for the current fiscal year, about 2% by fiscal 2027 and about 3% by fiscal 2028; M&A could lift it to roughly 4%, an estimated $1.1 billion to $1.2 billion of operating income.
- FY2024 to FY2025: $1.3 billion improvement in operating margin and recurring operating EBITDA from a $62 million loss to an $837 million gain.
- Ascension's acquisition of AMSURG shows shift to ambulatory care (CFO at HFMA)
- Ascension CFO Saurabh Tripathi, on an HFMA conference panel (June 2026), said the system is pivoting to provide more care in the ambulatory setting after closing the $3.9 billion AMSURG acquisition (about 300 ASCs).
- "One thing we will never walk away from is our mission …. but we do want to take the care out of hospitals."
- Patients prefer outpatient procedures so they can get home faster; Ascension is following that preference.
- On AMSURG integration: "Making it successful is a whole other journey."
- Ascension now owns 94 hospitals, down from 140, after intentionally shrinking its footprint; building another brick-and-mortar hospital is unlikely unless it is vital to a community.
- Decision test: "How do we serve our patients in the most efficient manner, the lowest cost setting, and providing care that the patients need?"
- Fitch's Kevin Holloran credited the ambulatory push; Fitch had downgraded Ascension from AA+ to AA, citing more than $4 billion of additional debt.
Questions about Ascension
What does Ascension do?
Ascension is a Catholic, nonprofit US health system that runs hospitals, ambulatory surgery centers, physician practices, pharmacies and senior living facilities across 35 states and the District of Columbia.
What is Ascension's revenue?
Total operating revenue was $24,473 million in the fiscal year ended June 30, 2026, and $6,447 million in the quarter ended September 30, 2026.
How many employees does Ascension have?
Ascension had about 98,500 associates and 27,700 aligned providers at September 30, 2026.
Who leads Ascension?
Eduardo Conrado has been President and CEO since January 1, 2026, succeeding Joseph Impicciche; Saurabh Tripathi is Executive Vice President and CFO.
Why did Ascension buy AmSurg?
AmSurg's surgery centers let Ascension move lower-acuity procedures out of hospitals into lower-cost settings and enter 25 new markets with physician partners, without building new hospitals.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)